CoWIN Website Recovers from Early Crash, But Vaccine Slots Remain Scarce
The CoWIN website faced an early crash today, April 28, as millions attempted to register for the COVID-19 vaccine in India. The crash affected not just the CoWIN mobile app but also alternative registration methods like the UMANG and Aarogya Setu mobile apps, causing frustration among users.
Initial Hurdles and Recovery
Initially, the CoWIN website experienced issues with sending one-time-passwords (OTPs), adding to the registration woes. However, the platform swiftly recovered, allowing users to receive OTPs and proceed with the registration process. Despite this quick fix, challenges persisted, particularly in finding available vaccination slots.
Registration Challenges and Slot Availability
To register successfully, users must navigate the main CoWIN portal, enter their phone number, and obtain a valid OTP within a three-minute window. However, even after completing these steps, some users encountered difficulties in selecting photo ID types or gender, crucial for completing the registration process.
Shortage of Slots for 18 to 44-Year-Olds
One of the major issues highlighted by users is the scarcity of vaccination slots, especially for individuals aged 18 to 44. While some slots are visible for those aged 45 and above, younger age groups face challenges in securing appointments.
Uncertainty and Lack of Clarity
The confusion surrounding vaccine availability and registration processes has left many wondering about the government’s plans for expanding the vaccination drive. Despite efforts to communicate updates through social media channels, gaps in information and clarity persist, contributing to the frustration among citizens seeking vaccination.
Ongoing Efforts and Future Steps
As the CoWIN website stabilizes and addresses initial glitches, efforts are ongoing to streamline the registration process and ensure equitable access to vaccine slots across all age groups. Clarity regarding vaccine supply and distribution plans remains essential to alleviate uncertainties and facilitate a smoother vaccination drive.
